Pilot trial of unlabeled and indium-111-labeled anti-prostate-specific membrane antigen antibody J591 for castrate metastatic prostate cancer.
Morris MJ, Divgi CR, Pandit-Taskar N, Batraki M, Warren N, Nacca A, Smith-Jones P, Schwartz L, Kelly WK, Slovin S, Solit D, Halpern J, Delacruz A, Curley T, Finn R, O'donoghue JA, Livingston P, Larson S, Scher HI.
Morris MJ, et al. Among authors: slovin s.
Clin Cancer Res. 2005 Oct 15;11(20):7454-61. doi: 10.1158/1078-0432.CCR-05-0826.
Clin Cancer Res. 2005.
PMID: 16243819
Clinical Trial.